Gene Query: CD33

Dataset Description Geneva Score
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 31.38
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 31.38
SRSF2 mutations impair hematopoiesis and alter exon recognition 28.2
Pharmacologic inhibition of STAT5 in AML 27.54
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 27.45
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 27.13
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 25.75
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 25.59
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 25.55
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 23.2
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 23.2
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 20.88
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 20.88
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 19.64
CircRNAome diversity in human mature B-cells, T-cells and monocytes 16.01
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 15.72
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 15.38
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 14.1
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 13.87
RNA-seq of CD33 KO and control HSPCs 13.16
Transcriptional profile in human S. haematobium infection 12.88
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 12.35
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 12.28
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 12.28
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 12.18
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 12.02
Gene expression changes associated with resistance to tagraxofusp (SL-401) 12.01
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 11.95
Targeting MTHFD2 in Acute Myeloid Leukemia 11.93
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 11.85
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 11.62
The pause-initiation limit restricts transcription activation in human cells 11.07
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 10.76
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 10.66
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 10.66
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 10.64
Transcriptome wide analysis of classically and alternatively activated macrophages 10.61
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 10.05
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 9.79
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.64
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 9.44
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 9.07
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.83
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 8.4
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 8.4
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.09
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.09
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.07
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.07
CHD1 regulates cell fate determination by activation of differentiation-induced genes 7.89
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 7.8
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 7.74
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.7
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 7.54
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.44
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 7.32
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 7.21
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 7.06
RNA-Seq from human ILC transitional populations 7.06
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.03
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.03
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 6.97
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 6.88
RNA sequencing of primary human platelets and in vitro cell lines 6.76
Single cell transcriptome of peritoneal cells 6.6
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 6.23
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 6.2
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 6.03
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.95
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.88
Dysregulated immune system networks in war veterans with PTSD 5.77
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.76
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.74
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 5.56
Transcriptome analysis of SKI knock-out in HL60 cells 5.55
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 5.55
Transcriptional profiling of microglia; current state of the art and future perspectives 5.43
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.32
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 5.32
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 5.31
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 5.28
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.19
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.19
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 5.01
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 5.01
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 5.01
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.97
Aging-associated patterns in the expression of human endogenous retroviruses 4.86
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.85
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 4.85
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 4.85
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 4.82
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 4.78
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 4.78
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 4.75
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.73
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 4.73
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 4.73
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 4.73
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.58
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 4.57
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 4.52
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 4.52
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 4.44
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 4.44
Reprogrammed myeloid cell transcriptomes in NSCLC 4.43
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.17
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.16
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 4.16
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 4.09
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.93
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.93
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.9
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.88
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.88
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.87
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.85
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.82
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.8
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.76
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.74
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.73
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.7
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 3.58
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.55
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.52
Gene expression signatures of innate lymphoid cells from human blood 3.51
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.49
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.49
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.48
Integrating single-cell transcriptomic data across different conditions, technologies, and species 3.47
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.43
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.42
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.41
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.25
Trascriptome of thyroid cancer-induced macrophages 3.18
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.16
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.11
Identification of renal resident macrophages across species 3.03
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.97
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.96
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.96
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 2.95
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.86
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.86
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 2.83
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.83
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.82
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 2.78
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.74
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.74
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.67
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.6
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.6
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 2.57
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 2.57
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.56
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.52
RNA-seq analysis of AML cells in response to ASLAN003 2.52
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.47
Transcriptome sequencing of K-562 cells 2.45
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 2.42
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.41
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 2.41
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 2.39
Gene expression profile of multiple myeloma cell lines treated with CB-5083 2.38
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.37
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.37
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.36
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.34
TAF1 is critical for AE driven leukemogenesis 2.34
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.32
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.25
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 2.24
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 2.24
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.24
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.22
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 2.2
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 2.19
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 2.19
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.19
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.16
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.16
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 2.14
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 2.14
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 2.1
RNA expression analysis upon JMJD1C depletion 2.1
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 2.1
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.09
Intron retention induced by microsatellite expansions as a disease biomarker. 2.09
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.07
RNA-seq of stable and unstable section of human atherosclerotic plaques 2.05
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.05
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 2.02
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 2.02
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 2.02
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 1.99
Leucegene: ALL sequencing 1.97
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 1.97
Differentially expressed genes post knock down of lincDUSP26 1.96
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.95
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.94
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.94
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.94
Transcriptome-wide identification of CELF2 functional targets in T cells 1.92
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.89
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.89
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.89
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 1.87
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.87
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 1.82
Differential gene expression profiles in imatinib-resistant cell lines 1.81
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 1.81
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 1.81
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.79
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 1.79
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.76
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 1.75
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.75
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.74
A map of gene expression in neutrophil-like cell lines 1.68
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.65
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 1.65
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.65
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 1.64
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.63
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.61
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.6
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 1.59
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 1.59
The evolution of N6-methyladenosine in primates 1.57
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.56
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.56
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 1.54
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.5
Accurate annotation of human protein-coding small open reading frames 1.5
Effect of PRDM11 depletion in U2932 cells 1.49
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 1.48
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 1.48
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.48
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.48
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 1.47
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.46
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.46
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 1.45
Peptidomimetic blockade of MYB in acute myeloid leukemia 1.45
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.45
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.44
U2AF1 mutations alter splice site recognition in hematological malignancies 1.44
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 1.43
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 1.43
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 1.43
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.41
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.4
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 1.4
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 1.4
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.39
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.39
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 1.38
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.37
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 1.36
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.35
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.35
Dynamic 3D chromosomal landscapes in acute leukemia 1.35
Transcriptome Profiling of Human Primary Monocytes 1.32
Global analysis of enhancer targets: Mosaic-seq 1.31
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.31
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.31
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.31
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.29
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 1.28
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.27
RNA-Seq and expression data from human adipose tissue 1.27
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.27
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.27
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 1.26
Microglia innatly develop within cerebral organoids 1.25
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.24
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.23
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.22
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.22
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.22
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 1.22
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.21
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 1.21
MicroRNA-125a-5p overexpression in human macrophages 1.2
Transcriptomic profiling of human peripheral blood-derived mast cells 1.18
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.18
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.17
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 1.15
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 1.13
Leucegene: AML sequencing (part 6) 1.1
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.1
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 1.09
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.09
Single-Cell Genotyping of Transcriptomes 1.09
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.08
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 1.07
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.07
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.06
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.06
Identification of long noncoding RNAs in T-ALL cell lines 1.06
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.06
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 1.04
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 1.04
quanTIseq: quantifying immune contexture of human tumors 1.04
Bone marrow derived human B cells [normal proB] 1.03
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 1.03
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.01
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.01
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.01
Generation and functional characterization of MDSC-like cells 1.01
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 1.0
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.0
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.98
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.98
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.98
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.97
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.97
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.97
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.97
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.97
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.96
CD86 regulates a pro-survival signal in myeloma cells 0.96
Effects of rFVIIIFc on human macrophages 0.95
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.95
Macrophage Ad5f35 M2 Challenge 0.94
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.93
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.93
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.92
BCL11B 0.92
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.91
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.91
DRB/GRO-Seq -/+ UV 0.91
Transcriptomic analysis of human macrophages in 3D 0.9
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.9
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.89
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.89
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 0.88
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.87
Transcriptomes in healthy and CHB fetal hearts 0.85
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.85
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.84
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.84
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.84
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.84
Macrophage Ad5f35 PhenoMap 0.83
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.81
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.81
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.8
Analyses of T-ALL (COG study) 0.79
RNA sequencing of T-ALL (COG study) 0.79
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.79
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.77
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.77
NAPRT activation of macrophages 0.77
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.75
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.74
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.74
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.73
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 0.73
Transcription control by the ENL YEATS domain in acute leukemia 0.73
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 0.73
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.73
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 0.72
Neurofibroma 0.72
MARCKS and lnc-MARCKS act as inflammation regulators 0.7
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.7
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.69
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.69
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.68
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.68
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.67
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.64
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.63
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 0.62
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.62
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 0.6
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 0.6
The pioneer factor CEBPA modulates vitamin D signaling 0.59
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.59
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.57
A single cell reference map for human blood and tissue T cell activation 0.56
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.56
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.55
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.55
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 0.55
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.54
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.53
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.53
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.52
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.52
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.52
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.51
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.5
Specific molecular signatures underlie response to decitabine in CMML 0.5
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.5
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.5
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.49
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.49
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 0.48
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 0.48
Transcriptome analysis of peripheral blood monocytes 0.47
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 0.47
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.44
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 0.44
Irf9 function in immunity in mouse 0.44
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.43
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.43
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.42
RNA-seq in endometrial stromal tumors 0.41
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.39
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.39
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.39
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.39
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.38
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.38
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.38
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.38
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.38
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.38
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.38
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.37
RNA-seq of primary patient AML samples 0.37
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.36
LncRNA expression profiling of ischemic stroke patients 0.36
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.36
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.33
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.32
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.32
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.31
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.31
Characterization of human ILC2 subsets 0.31
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.31
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 0.3
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.29
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.29
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.29
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.28
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 0.26
A Unique Epigenomic Landscape Defines Human Erythropoiesis 0.26
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.26
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.26
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.26
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.25
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.24
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.24
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.23
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.23
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 0.23
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.22
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.22
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.21
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.2
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.2
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.2
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.2
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 0.2
Proliferation-correlated expression 0.19
Expression analysis of the TAF1 syndrome 0.19
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.18
Targeted enhancer activation by a subunit of the integrator complex 0.17
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.17
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.16
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.16
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.15
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.15
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.14
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.14
Hepatosplenic T cell lymphoma 0.14
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 0.11
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.09
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.08
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.08
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.08
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.08
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.08
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.08
RNA-seq data 0.07
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.07
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.06
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.05
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.04
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.03
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.03
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.02
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.02
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.01
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.01
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.01
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.01
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.0
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.0
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.0
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation